Assoc. Prof. ASLI KOÇ


Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

Biyokimya Anabilim Dalı


WoS Research Areas: Life Sciences (Life), Biochemical Research Methods

Avesis Research Areas: Biochemistry

Metrics

Publication

78

Publication (WoS)

27

Publication (Scopus)

29

Citation (WoS)

165

H-Index (WoS)

10

Citation (Scopus)

172

H-Index (Scopus)

10

Project

23

Thesis Advisory

6

Open Access

10
UN Sustainable Development Goals

Dissertations

2011

2011

Doctorate

RAW 264.7 makrofaj hücrelerinde nitrik oksit sentezi üzerine L-karnitinin etkisi

Ankara University, Sağlık Bilimleri Enstitüsü, Biyokimya (Dr) (Eczacılık)

Research Areas

Avesis Research Areas: Biochemistry
WoS Research Areas: Life Sciences (Life), Biochemical Research Methods

Research Areas Based on Academic Activities

Avesis Research Areas

    WoS Research Areas

      Scopus Research Areas

        Academic Positions

        2022 - Continues

        2022 - Continues

        Associate Professor

        Ankara University, Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

        2017 - Continues

        2017 - Continues

        Assistant Professor

        Ankara University, Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

        2009 - 2011

        2009 - 2011

        Research Assistant

        Ankara University, Eczacılık Fakültesi, Temel Eczacılık Bilimleri Bölümü

        Courses

        Doctorate

        Doctorate

        Hücresel Sinyal İletimi

        Uzmanlık alan dersi

        Hormonlar

        Proteinlerin kimyası ve yapısal Analizi

        Postgraduate

        Postgraduate

        Hücre Biyolojisi

        Ölüm Nedeninin saptanmasında Postmortem Biyokimya

        Su ve mineral metabolizması

        Undergraduate

        Undergraduate

        Biochemical Basis of Disease

        Araştırma Projesi I

        Beslenme Biyokimyası

        Araştırma Projesi II

        Biochemistry I

        Biyokimya 1

        Hastalıkların Biyokimyasal Temeli

        Nutritional Biochemistry

        Biochemistry II

        Biyokimya Uygulama

        Biyokimya II

        Biochemistry Practice

        Articles

        All (15)
        SCI-E, SSCI, AHCI (12)
        SCI-E, SSCI, AHCI, ESCI (12)
        Scopus (12)
        TRDizin (1)
        Other Publications (2)

        Papers Presented at Peer-Reviewed Scientific Conferences

        2024

        2024

        1. ICRT14 INDUCES APOPTOSIS THROUGH MLH1 OVEREXPRESSION IN AML CELL LINE

        HEKMATSHOAR Y., ÖZKAN T., KARABAY A. Z., ALTINOK GÜNEŞ B., KARADAĞ GÜREL A., KOÇ A., et al.

        14th International Symposium on Pharmaceutical Sciences (ISOPS), Ankara, Turkey, 25 - 28 June 2024, (Summary Text)

        2021

        2021

        3. Role of exosomal miRNAs in imatinib resistance of chronic myeloid leukemia

        KARABAY A. Z., ÖZKAN T., KOÇ A., KARADAĞ GÜREL A., Hekmatshoar Y., SUNGUROĞLU A., et al.

        13th International Symposium on Pharmaceutical Sciences, Turkey, 22 June 2021, (Summary Text)

        2021

        2021

        4. Evaluation of the effects of SIRT5 modulators on the apoptosis of K562 cells and and SIRT5 and cytochrome c proteins

        KOÇ A., ÖZKAN T.

        13th International Symposium on Pharmaceutical Sciences, Turkey, 22 June 2021, (Summary Text)

        2021

        2021

        5. Effect of Poloxamer 407 (Pluronic F-127) on the proliferation of K562 imatinib sensitive and resistance chronic myleogenous cell line

        KOÇ A.

        2. International Baku Scientific Researchers Conference Baku, Azerbeijan, Odlar Yurdu University, Azerbaijan, 28 April 2021, (Full Text)

        2020

        2020

        6. Effect of Lipoic Acid Taurine Combination on Activated Raw 264.7 Macrophages

        KOÇ A., Yaprak A., ÖZKAN T.

        3rd International Hippocrates Congress on Medicinal and Health Sciences, Ankara, Turkey, 06 March 2020, (Full Text)

        2018

        2018

        7. Effects of Probucol on K562 chronic myelogenous leukemia cell line

        AKTAN F., KOÇ A., BÜYÜKBİNGÖL Z., KARABAY A. Z.

        16th Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease (WCIRDC), 29 November - 01 December 2018, (Summary Text)

        2018

        2018

        12. Synthesis and Anticancer Activity Studies of Some Novel Indole Retinoid Derivatives

        Gurkan-Alp A. S., Koç A., Karabay A. Z., Büyükbingöl M. E.

        International Symposium on Pharmaceutical Sciences (ISOPS-12), Ankara, Turkey, 26 - 29 June 2018, pp.399, (Summary Text)

        2018

        2018

        14. Effect of secondary metabolites of Lactobacillus species isolated from vaginal cultures on the proliferation of HCT 116 colon cancer cells.

        ERYILMAZ M., KOÇ A., GÜRPINAR S. S., PALABIYIK İ. M., GERÇEKER D.

        6th Congress of the Microbiologists of Macedonia with International Participation, and FEMS Supported Symposium entitled ”Emerging Infections”, Ohrid, Macedonia, 30 May - 02 June 2018, (Summary Text) Sustainable Development

        2016

        2016

        16. Retinoid analoglarının kronik miyeloid lösemi k562 hücrelerindeki apoptotik etkileri

        Koç A., Karabay A. Z., Özkan T., Gurkan-Alp A. S., Aktan F., Büyükbingöl Z., et al.

        23. Ulusal Biyoloji Kongresi, Gaziantep, Turkey, 5 - 09 September 2016, pp.183, (Summary Text)

        2016

        2016

        17. Retinoid Analoglarının Kronik Miyeloid Lösemi K562 Hücrelerindeki Apoptotik Etkileri

        KOÇ A., KARABAY A. Z., Özkan T., ALP A. S., AKTAN F., BÜYÜKBİNGÖL Z., et al.

        23. Ulusal Biyoloji Kongresi, Gaziantep, Turkey, 5 - 09 September 2016, pp.183, (Summary Text)

        2015

        2015

        19. Effects of indole alpha lipoic acid derivatives on cell viability parameters in K562 leukemia cell line

        Karabay A. Z., Koç A., Gurkan-Alp A. S., Büyükbingöl Z., Büyükbingöl M. E.

        11th International Symposium on Pharmaceutical Sciences (ISOPS-11), Ankara, Turkey, 9 - 12 June 2015, pp.43, (Summary Text)

        2015

        2015

        20. Effect of microenvironment on imatinib resistance of K562 cells

        KARABAY A. Z., KOÇ A., AKTAN F., BÜYÜKBİNGÖL Z.

        40th FEBS congress The Biochemical Basis of Life, Germany, 04 July 2015, (Summary Text)

        2014

        2014

        24. Effect of imatinib on nitrite levels in LPS/IFNγ activated RAW 264.7 macrophages.

        KARABAY A. Z., KOÇ A., ÖZKAN T., BÜYÜKBİNGÖL Z., SUNGUROĞLU A., AKTAN F.

        Lipid Maps Anual Meeting 2014: Lipidomics impact on Cell Biology, Inflammation and Metabolic Disease, 13 - 14 May 2014, (Summary Text)

        2013

        2013

        25. Differences between akirin protein levels in imatinib resistant and sensitive K562 cell lines

        KOÇ A., KARABAY A. Z., ÖZKAN T., ALTINOK GÜNEŞ B., BÜYÜKBİNGÖL Z., SUNGUROĞLU A., et al.

        Molecular Life Sciences International Symposium of the German Society for Biochemistry and Molecular Biology, 3 - 06 October 2013, (Summary Text)

        2013

        2013

        26. Interaction of NFkB and akirin proteins in imatinib resistant and sensitive K562 cell lines.

        KOÇ A., ÖZKAN T., KARABAY A. Z., SUNGUROĞLU A., BÜYÜKBİNGÖL Z., AKTAN F.

        Analysis of autophagy regulation: Discussion of recent research and new technologies meeting., 03 October 2013, (Summary Text)

        2013

        2013

        28. Effect of Nilotinib on inflammatory markers in LPS/IFNγ activated RAW 264. 7 macrophages.

        ÖZKAN T., KOÇ A., KARABAY A. Z., AKTAN F., SUNGUROĞLU A., BÜYÜKBİNGÖL Z.

        Analysis of autophagy regulation: Discussion of recent research and new technologies meeting., 03 October 2013, (Summary Text)

        2010

        2010

        30. Effect of Poloxamer 407 on Nitric Oxide Production and Cell Viability in LPS Induced RAW 264.7 Macrophage Cell Line.

        KOÇ A., AKTAN F.

        8. Annual World Congress on Insulin Resistance, Diabetes and Cardiovascular Disease, 4 - 06 November 2010, (Summary Text)

        2010

        2010

        31. Effect of wnt3a or lithium chloride preconditioning on nitric oxide production in RAW264.7 macrophages and K562 leukemic cell line.

        Karabay A. Z., Özkan T., Koç A., Karadağ A., Altınok Güneş B., Büyükbingöl Z., et al.

        35th Congress of the Federation-ofmEuropean-Biochemical-Societies, Gothenburg, Sweden, 26 June - 01 July 2010, pp.147, (Summary Text)

        Books

        2021

        2021

        1. İlaç keşfinde biyokimya

        Karabay A. Z., Koç A.

        in: İlaç keşfi ve geliştirilmesi, Mehmet Alp, Editor, Akademisyen Yayınevi Kitabevi, Ankara, pp.1-254, 2021

        Funded Projects

        2025 - 2026

        2025 - 2026

        Trimipramin’in akut miyeloid lösemi (AML) hücre hattı olan HL-60 hücre serisi üzerindeki olası sitotoksik etkileri

        TUBITAK Project , 2209-A - Üniversite Öğrencileri Araştırma Projeleri Destekleme Programı

        Koç A.

        2021 - 2023

        2021 - 2023

        Sitalopram ve Bromokriptinin kombine etkilerinin, Caco-2 insan kolorektal adenokarsinoma hücre serisinde değerlendirilmesi

        Project Supported by Higher Education Institutions , BAP MSc

        Koç A. (Executive)

        2018 - 2019

        2018 - 2019

        Sirtüin 5'in K562 kronik miyeloid lösemi hücrelerinin proliferasyonu üzerindeki etki mekanizması

        Project Supported by Higher Education Institutions , BAP Other

        KOÇ A. (Executive)

        2018 - 2019

        2018 - 2019

        Sirtüin 5’in K562 Kronik Miyeloid Lösemi hücrelerinin proliferasyonu üzerindeki etki mekanizması

        Project Supported by Higher Education Institutions , BAP Research Project

        Koç A. (Executive)

        2016 - 2017

        2016 - 2017

        Probukolün K562 kronik miyeloid lösemi hücrelerindeki apoptotik etkileri

        Project Supported by Higher Education Institutions , BAP Research Project

        KOÇ A., KARABAY A. Z. (Executive)

        2011 - 2013

        2011 - 2013

        Beta katenin Nükleer faktör kabba B ve Akirin Proteinlerinin Birliktelikleri ve Kronik Myeloid Lösemide Imatinib Direncindeki Rolleri

        TUBITAK Project , 1001 - Program for Supporting Scientific and Technological Research Projects

        Koç A., Karabay A. Z., Özkan T., Sunguroğlu A., Aktan F. (Executive)

        Activities in Scientific Journals

        2018 - Continues

        2018 - Continues

        ANKARA UNIVERSITESI ECZACILIK FAKULTESI DERGISI

        Committee Member

        Roles in Event Organizations

        Ekim 2022

        Ekim 2022

        PHARMANKARA III Sustainable Development

        Scientific Congress

        Sezgin Bayındır Z., Eryılmaz M., KOÇ A.
        Ankara, Turkey
        

        Citations

        Total Citations (SCOPUS): 220

        h-index (SCOPUS): 10

        Jury Memberships

        July-2021

        July 2021

        PhD Thesis Monitoring Committee Member

        Saliha Şeyma Şahinler TİK ÜYELİĞİ - Ankara Üniversitesi